The RENAISSANCE (AIO-FLOT5) Trial: Effect of Chemotherapy Alone vs. Chemotherapy Followed by Surgical Resection on Survival and Quality of Life in Patients With Limited-Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction – A Phase III Trial of the German AIO/CAO-V/CAOGI

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3918-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Combination Chemotherapy With Paclitaxel, Cisplatin and Fluorouracil for Patients With Advanced and Metastatic Gastric or Esophagogastric Junction Adenocarcinoma: A Multicenter Prospective Study

Chinese Journal of Cancer Research
Cancer ResearchOncology
2012English

Nomogram Predicted Survival of Patients With Adenocarcinoma of Esophagogastric Junction

World Journal of Surgical Oncology
SurgeryOncology
2015English

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

The Effect of Chemotherapy on Quality of Life in Patients With Lung Carcinoma

Gulhane Medical Journal
Medicine
2012English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers With Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial

Journal of Biomedicine and Biotechnology
2011English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2018English

P2.16-03 CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy